A recent Times Higher Education article highlights universities that are pushing the boundaries as “life science challengers.” Emory is ranked in this category and chemistry research co-discovered by Dr. Dennis Liotta is highlighted.
David Stephens, vice-president for research at Emory, said that the institution had “realised its greatest success in commercialising research discoveries in the field of infectious diseases. For example, nine out of 10 US HIV/Aids patients, and thousands more globally, are on life-saving drugs discovered at Emory”.
https://scholarblogs.emory.edu/chemistry/tag/emtriva/
“The Center for AIDS Research at Emory University (CFAR) received a five-year, $10 million award from the National Institutes of Health (NIH) to further its work in decreasing HIV incidence, improving the well-being of infected individuals, training the next generation of researchers and clinical leaders, and ultimately finding a vaccine and cure for HIV.”
“Now, Emory ranks sixth in the country for HIV/AIDS NIH funding, with $63.8 million in HIV/AIDS research support.”
http://news.emory.edu/stories/2017/05/CFAR_funding_renewal/index.html